NIH
-
Gene interactions and cavities
Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay. Read MoreSep 30, 2013
-
Metabolic profiling of vision loss
A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis. Read MoreSep 27, 2013
-
Cell changes en route to stomach cancer
Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer. Read MoreSep 26, 2013
-
Vaccine Research Program lands major NIH renewal
The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units. Read MoreSep 26, 2013
-
VU testing vaccine against new flu threat
Vanderbilt’s Vaccine and Treatment Evaluation Unit (VTEU) is one of nine U.S. sites funded by the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH), to test the effectiveness of a vaccine to protect against the H7N9 bird flu that emerged in China this spring. Read MoreSep 19, 2013
-
VUCast: Preventing the next pandemic
Researchers work to prevent possible bird flu pandemic How stars solve mysteries of the universe And conquering the video gaming industry Vandy style? All this and more in this week’s VUCast, Vanderbilt’s online newscast. Watch now. [vucastblurb]… Read MoreSep 18, 2013
-
Fishing for new anti-cancer drugs
Vanderbilt investigators used an in vivo screen in zebrafish to identify a potential new anti-cancer drug. Read MoreSep 18, 2013
-
Mapping brain membrane proteins
New mass spectrometry imaging methods will enable studies of the distribution and identification of membrane proteins directly within tissues. Read MoreSep 16, 2013
-
Cancer nanomedicines on target
Therapeutic nanoparticles may offer a powerful new way to image and treat cancer at the same time. Read MoreSep 13, 2013
-
VU study identifies DNA changes in drug-resistant cancer cells
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines. Read MoreSep 12, 2013
-
Federal grant bolsters pulmonary fibrosis research
Lisa Young, M.D., associate professor of Pediatrics and Medicine and Cell Biology, has been awarded a five-year, $1.9 million National Institutes of Health grant to study what causes cellular dysfunction and pulmonary fibrosis in patients with Hermansky-Pudlak syndrome (HPS). Read MoreSep 12, 2013
-
‘Proofreader’ key to coronavirus growth
A coronavirus protein is required for replication of the viral genome and may be a good treatment target for SARS and other diseases caused by coronaviruses. Read MoreSep 12, 2013
-
Ellen Fanning, DNA researcher and mentor of young scientists, dies
Ellen Fanning, Stevenson Professor of Biological Sciences and a professor of the Howard Hughes Medical Institute, died on Sunday morning, Sept.1, after a lengthy battle with amyotrophic lateral sclerosis (ALS). She was 67 years old. Read MoreSep 3, 2013
-
Probing intestinal immune cell roles
A new in vitro system will allow investigators to explore how immune system T cells develop specialized functions. Read MoreAug 28, 2013
-
Tumor factor spurs blood vessel growth
A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies. Read MoreAug 26, 2013
-
Pregnancy promoter and protector
Alkaline phosphatase enzymes appear to play roles in promoting pregnancy and in protecting the uterus from bacterial infection. Read MoreAug 23, 2013
-
Overcoming resistance in ovarian cancer
The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments. Read MoreAug 22, 2013
-
Universitywide limited submission opportunity: Faculty Scholars Program
Vanderbilt University may nominate one candidate for the 2014 Faculty Scholars Program. Read MoreAug 16, 2013
-
Universitywide limited submission opportunity: Simons Foundation
Vanderbilt may nominate one candidate for the Simons Investigators in the Mathematical Modeling of Living Systems (MMLS) award, which supports junior faculty for five years at $100,000 per year. Read MoreAug 16, 2013
-
$5.2M NIH grant bolsters colorectal cancer research
Robert Coffey Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, has received a five-year, $5.2 million grant from the National Institutes of Health (NIH) to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Read MoreAug 15, 2013